<DOC>
	<DOCNO>NCT02492672</DOCNO>
	<brief_summary>The current registry undertaken assess long-term ( 12 month ) safety tolerability Venofer pediatric population chronic kidney disease require intravenous iron maintenance therapy .</brief_summary>
	<brief_title>Registry Evaluate Maintenance Treatment With Venofer Pediatric Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>This multicenter , observational , prospective registry collect long-term ( 12-month ) safety , tolerability , laboratory data . Subjects screen inclusion criterion hemodialysis ( HD ) , peritoneal dialysis ( PD ) non-dialysis dependent ( NDD ) chronic kidney disease ( CKD ) . Treatment-emergent adverse event ( adverse event start time 1st dose Venofer administer study ) collect via site entry data web-based system . Each research investigator responsible enter adverse event information appropriate clinical research form well report event sponsor . Number Subjects : 50 evaluable subject ( i.e. , take lease one dose Venofer safety data record 12 month time point ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Age great equal 2 less equal 17 year Subjects must diagnosis either NDDCKD , PDCKD HDCKD Dialysis patient must stable periotoneal ( PD ) hemodialysis ( HD ) regimen 1 month Patient agree participate registry ( i.e. , provide adverse event information ) 12 month</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>